Lipogems technology is a minimally invasive regenerative medicine approach that involves using a patient’s own adipose (fat) tissue to promote tissue repair and regeneration in damaged tissues, including the knee joint.
During the procedure, a small amount of adipose tissue is harvested from the patient, typically from the abdomen or thigh area, using a special Lipogems device. The harvested tissue is then processed using a proprietary technique that separates the adipose tissue into small clusters of cells and removes any impurities.
The resulting “microfat” tissue is then injected into the affected area, such as the knee joint, where it can promote tissue repair and regeneration. The microfat tissue contains a variety of cells, including stem cells, which can differentiate into the types of cells needed to repair damaged tissues. The microfat tissue also contains a range of growth factors and other bioactive proteins that can stimulate tissue repair and reduce inflammation.
Lipogems technology is often used to treat knee conditions such as osteoarthritis, ligament injuries, and cartilage damage. The procedure is minimally invasive and typically requires little downtime, with most patients able to return to normal activities within a few days.
While Lipogems technology has shown promise as a treatment for knee conditions, the effectiveness of the treatment can vary depending on the individual patient’s condition, the severity of their symptoms, and other factors. Researchers are continuing to study the potential of Lipogems technology and to develop new techniques for optimizing its effectiveness.